Sysmex Co. (OTCMKTS:SSMXY - Get Free Report)'s share price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $18.57 and traded as low as $17.84. Sysmex shares last traded at $17.89, with a volume of 76,551 shares.
Sysmex Stock Up 5.2 %
The company has a quick ratio of 2.42, a current ratio of 3.19 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $11.80 billion, a PE ratio of 36.87 and a beta of 1.08. The business has a 50-day moving average price of $18.45 and a 200-day moving average price of $19.00.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $0.17 earnings per share (EPS) for the quarter. Equities research analysts forecast that Sysmex Co. will post 0.57 earnings per share for the current fiscal year.
Sysmex Company Profile
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
See Also
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
